Overview
Jin Kim practices in Songnam, Republic of Korea. Kim is rated as an Advanced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Their top areas of expertise are Stomach Cancer, Cholangiocarcinoma (Bile Duct Cancer), Coronary Artery Spasm, Glossectomy, and Gastrectomy.
Their clinical research consists of co-authoring 413 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 25 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Stomach CancerKim isDistinguished. Learn about Stomach Cancer.
- Advanced
- AgranulocytosisKim isAdvanced. Learn about Agranulocytosis.
- AnginaKim isAdvanced. Learn about Angina.
- AtherosclerosisKim isAdvanced. Learn about Atherosclerosis.
- Cholangiocarcinoma (Bile Duct Cancer)
- Colorectal CancerKim isAdvanced. Learn about Colorectal Cancer.
- Coronary Artery Spasm
- Experienced
- Acoustic NeuromaKim isExperienced. Learn about Acoustic Neuroma.
- Acute Coronary SyndromeKim isExperienced. Learn about Acute Coronary Syndrome.
- AngioplastyKim isExperienced. Learn about Angioplasty.
- Atrial FibrillationKim isExperienced. Learn about Atrial Fibrillation.
- Autosomal Dominant Polycystic Kidney Disease
- B-Cell LymphomaKim isExperienced. Learn about B-Cell Lymphoma.